GB809105A - Processes for solubilising amorphous nystatin and compositions containing the same - Google Patents

Processes for solubilising amorphous nystatin and compositions containing the same

Info

Publication number
GB809105A
GB809105A GB18431/57A GB1843157A GB809105A GB 809105 A GB809105 A GB 809105A GB 18431/57 A GB18431/57 A GB 18431/57A GB 1843157 A GB1843157 A GB 1843157A GB 809105 A GB809105 A GB 809105A
Authority
GB
United Kingdom
Prior art keywords
nystatin
surfactant
sodium
specifications
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB18431/57A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Olin Corp
Original Assignee
Olin Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olin Corp filed Critical Olin Corp
Publication of GB809105A publication Critical patent/GB809105A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A morphone or non-crystalline nystatin (fungicidin) is rendered water soluble by the incorporation in the composition of an anionic surfactant. Sodium lauryl sulphate is the preferred surfactant but others such as the aryloxy polyalkylene ether sulphonates, e.g. sodium p-ter-octylphenoxy ethoxyethyl sulphonate, or sodium N-lauroyl sarcosinate may be used. The ratio of nystatin to the anionic surfactant may vary between 1 : 1.5 and 1 : 5 parts by weight. In the preferred process for producing the solubilized nystatin, non-crystalline nystatin is admixed with the surfactant, water is added and the pH of the solution adjusted to within the range 6-8, the solution is then filtered and freeze dried. Specifications 714,189, 796,512 and U.S.A. Specifications 2,115,192 and 2,628,187 are referred to.ALSO:Amorphous or non-crystalline nystatin (fungicidin) is rendered water-soluble by the incorporation in the composition of an anionic surfactant. Sodium lauryl sulphate is the preferred surfactant but others such as the aryloxy polyalkylene ether sulphonates, e.g. sodium p-teroctylphenoxyethoxyethyl sulphonate, or sodium N-lauroyl sarcosinate may be used. The ratio of nystatin to the anionic surfactant may vary between 1 : 0.5 and 1 : 5 parts by weight. The compositions may be incorporated in tablets, vaginal suppositories or in ointments, especially ointments having a base formed of polyethylene and a mineral oil. In the preferred process for producing the solubilized nystatin compositions, non-crystalline nystatin is admixed with the surfactant, water is added and the pH of the solution adjusted to within the range 6-8, the solution is then filtered and freeze dried. Specifications 714,189, 796,512, [both in Group IV (b)], and U.S.A. Specifications 2,115,192 and 2,628,187 are referred to.
GB18431/57A 1956-06-08 1957-06-11 Processes for solubilising amorphous nystatin and compositions containing the same Expired GB809105A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US809105XA 1956-06-08 1956-06-08

Publications (1)

Publication Number Publication Date
GB809105A true GB809105A (en) 1959-02-18

Family

ID=22160431

Family Applications (1)

Application Number Title Priority Date Filing Date
GB18431/57A Expired GB809105A (en) 1956-06-08 1957-06-11 Processes for solubilising amorphous nystatin and compositions containing the same

Country Status (1)

Country Link
GB (1) GB809105A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1296143B (en) * 1964-02-15 1969-05-29 Le Nii Antibiotika Process for the production of water-soluble sodium salts of the polyene antibiotics nystatin and levorin
US4185092A (en) * 1977-10-03 1980-01-22 E. R. Squibb & Sons, Inc. Purification of nystatin in an aqueous system
US5567685A (en) * 1994-08-16 1996-10-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Water-Soluble polyene conjugate
US6011008A (en) * 1997-01-08 2000-01-04 Yissum Research Developement Company Of The Hebrew University Of Jerusalem Conjugates of biologically active substances
WO2001068102A2 (en) * 2000-03-10 2001-09-20 Wisconsin Alumni Research Foundation Nystatin formulation having reduced toxicity
WO2020160443A1 (en) 2019-01-31 2020-08-06 Sigma-Aldrich Co. Llc Antifungal agents with improved water solubility

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1296143B (en) * 1964-02-15 1969-05-29 Le Nii Antibiotika Process for the production of water-soluble sodium salts of the polyene antibiotics nystatin and levorin
US4185092A (en) * 1977-10-03 1980-01-22 E. R. Squibb & Sons, Inc. Purification of nystatin in an aqueous system
US5567685A (en) * 1994-08-16 1996-10-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Water-Soluble polyene conjugate
US6011008A (en) * 1997-01-08 2000-01-04 Yissum Research Developement Company Of The Hebrew University Of Jerusalem Conjugates of biologically active substances
WO2001068102A2 (en) * 2000-03-10 2001-09-20 Wisconsin Alumni Research Foundation Nystatin formulation having reduced toxicity
WO2001068102A3 (en) * 2000-03-10 2002-04-04 Wisconsin Alumni Res Found Nystatin formulation having reduced toxicity
US6413537B1 (en) 2000-03-10 2002-07-02 Wisconsin Alumni Research Foundation Nystatin formulation having reduced toxicity
WO2020160443A1 (en) 2019-01-31 2020-08-06 Sigma-Aldrich Co. Llc Antifungal agents with improved water solubility

Similar Documents

Publication Publication Date Title
GB1458837A (en) Fabric conditioning compositions
FR2186530B1 (en)
GB809105A (en) Processes for solubilising amorphous nystatin and compositions containing the same
DE3170983D1 (en) Chemical blowing agent composition, its composition and use
SE7710021L (en) PROCEDURE FOR THE PREPARATION OF ETRAR
ES8300850A1 (en) Aqueous, soap-based liquid detergent composition.
GB791415A (en) Improvements in or relating to detergent compositions
GB893540A (en) Polyethylene diluted polypropylene
GB973952A (en) New water soluble mixed cellulose allyl ethers and a process for their manufacture
NL83998C (en)
ES399906A1 (en) Process for the production of dyestuff preparations
ES380767A1 (en) Method of preparing morpholino cyano-acrylamides
GB796633A (en) Improvements in or relating to anti-freeze mixtures
RO70855B (en) Process for preparing pharmacologically active sulphoxides
GB498743A (en) Improved product for treating water for toilet purposes
ES454457A1 (en) Aqueous shampoo compositions
US3069359A (en) Germicidal detergent composition
GB994353A (en) Improvements in detergent compositions
GB892015A (en) Improvements in the properties of hydraulic cements and a process of their manufacture
GB573589A (en) Improvements in or relating to the manufacture of alginic materials
GB833201A (en) Detergent compositions
GB688164A (en) Improvements in dentrifrices
GB1511835A (en) Process for forming a proteinaceous product
ES8106750A1 (en) Process for the preparation of concentrated solutions of metal complex dyestuffs free from sulfonic groups.
GB1518807A (en) Light-duty liquid dtergent compositions having enhanced skin mildnes properties